Global Nuclide Market Research Report 2026(Status and Outlook)
Description
Report Overview
A nuclide is an atomic nucleus defined by a specific number of protons and neutrons; radioactive nuclides emit α, β, or γ radiation during decay and are widely applied in medical diagnostics, therapy, industrial testing, and research. Medical nuclides play a central role in nuclear medicine imaging and radiotherapeutics: as radiotracers they enable molecular imaging (e.g., PET, SPECT) for early detection, staging, and treatment monitoring; as radiopharmaceuticals they serve in targeted and palliative therapies. The nuclide value chain spans isotope production (research reactors or cyclotrons), radiopharmaceutical manufacturing, specialized logistics, and radioactive waste handling — an ecosystem characterized by high technical barriers, strict regulation, and supply chains sensitive to national security and policy. With the rise of precision medicine and targeted radiotherapy, medical nuclides are evolving from single-use imaging agents toward integrated diagnostic-therapeutic, patient-tailored solutions, positioning themselves as strategic materials at the intersection of healthcare and life sciences.Nuclides, as core inputs for molecular imaging and radiotherapeutics, are seeing their clinical and commercial value amplified by precision medicine, radiopharmaceutical innovation, and cross-disciplinary R&D. Healthcare systems’ emphasis on early diagnosis and personalized therapy drives demand for radiotracers and therapeutic nuclides. Leading companies’ annual reports note strategic collaborations with pharmaceutical firms, imaging-equipment vendors, and hospitals — collaborations that accelerate technology translation and market penetration. Governmental and international initiatives that support critical isotope supply, build infrastructure, and fund supply-chain resilience further lower barriers and create scale opportunities. The nuclide sector is inherently subject to stringent regulation and complex compliance regimes: production, transport, and clinical use of radioactive materials are tightly controlled, raising entry and expansion costs. Upstream isotope capacity is concentrated in a limited number of reactors and accelerators; outages or policy shifts can quickly tighten supply — a vulnerability noted in corporate filings and public disclosures. Moreover, commercialization of radiopharmaceuticals requires alignment with regulatory approvals, reimbursement mechanisms, and hospital care pathways, making market rollout sensitive to multiple policy and stakeholder actions. Clinical demand is shifting from “imaging adjuncts” to integrated diagnostic-therapeutic workflows: molecular imaging is used for patient stratification and to guide personalized radiopharmaceutical dosing, while therapeutic nuclides are gaining traction in targeted therapies. Large tertiary hospitals remain early adopters, but regional and specialty centers are expanding access, broadening use cases and service networks. Annual reports and industry analyses indicate business models are evolving from pure supply to solution provision—co-developing clinical trials and services with hospitals and pharma partners—thereby enhancing customer stickiness and pricing power. Key upstream elements include isotope production capacity (reactors and cyclotrons), radiochemical precursors and labeling reagents, and radiation-tolerant high-performance materials and precision electronics. Scintillators, target materials, and radiation-hard components directly affect imaging quality and production throughput, while radiopharmaceutical synthesis depends on GMP facilities and cold-chain logistics. Government and corporate disclosures emphasize that localizing production capacity, diversifying supply sources, and investing in infrastructure are essential to improve supply stability and enable sustainable industry growth.
The global Nuclide market size was estimated at USD 4125.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclide market.
Global Nuclide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Curium
MDS Nordion
IRE (Institute for Radioelements)
NTP Radioisotopes
JSC Isotope
ANM (ANSTO Nuclear Medicine)
Nusano
International Isotopes
NorthStar Medical Radioisotopes
China Isotope & Radiation
NRG
Polatom
ASP Isotopes
Rosatom
Eckert & Ziegler
Market Segmentation (by Type)
Tc-99m
F-18
I-131
Co-60
Other
Market Segmentation (by Application)
Industry
Medical
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclide Market
Overview of the regional outlook of the Nuclide Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
A nuclide is an atomic nucleus defined by a specific number of protons and neutrons; radioactive nuclides emit α, β, or γ radiation during decay and are widely applied in medical diagnostics, therapy, industrial testing, and research. Medical nuclides play a central role in nuclear medicine imaging and radiotherapeutics: as radiotracers they enable molecular imaging (e.g., PET, SPECT) for early detection, staging, and treatment monitoring; as radiopharmaceuticals they serve in targeted and palliative therapies. The nuclide value chain spans isotope production (research reactors or cyclotrons), radiopharmaceutical manufacturing, specialized logistics, and radioactive waste handling — an ecosystem characterized by high technical barriers, strict regulation, and supply chains sensitive to national security and policy. With the rise of precision medicine and targeted radiotherapy, medical nuclides are evolving from single-use imaging agents toward integrated diagnostic-therapeutic, patient-tailored solutions, positioning themselves as strategic materials at the intersection of healthcare and life sciences.Nuclides, as core inputs for molecular imaging and radiotherapeutics, are seeing their clinical and commercial value amplified by precision medicine, radiopharmaceutical innovation, and cross-disciplinary R&D. Healthcare systems’ emphasis on early diagnosis and personalized therapy drives demand for radiotracers and therapeutic nuclides. Leading companies’ annual reports note strategic collaborations with pharmaceutical firms, imaging-equipment vendors, and hospitals — collaborations that accelerate technology translation and market penetration. Governmental and international initiatives that support critical isotope supply, build infrastructure, and fund supply-chain resilience further lower barriers and create scale opportunities. The nuclide sector is inherently subject to stringent regulation and complex compliance regimes: production, transport, and clinical use of radioactive materials are tightly controlled, raising entry and expansion costs. Upstream isotope capacity is concentrated in a limited number of reactors and accelerators; outages or policy shifts can quickly tighten supply — a vulnerability noted in corporate filings and public disclosures. Moreover, commercialization of radiopharmaceuticals requires alignment with regulatory approvals, reimbursement mechanisms, and hospital care pathways, making market rollout sensitive to multiple policy and stakeholder actions. Clinical demand is shifting from “imaging adjuncts” to integrated diagnostic-therapeutic workflows: molecular imaging is used for patient stratification and to guide personalized radiopharmaceutical dosing, while therapeutic nuclides are gaining traction in targeted therapies. Large tertiary hospitals remain early adopters, but regional and specialty centers are expanding access, broadening use cases and service networks. Annual reports and industry analyses indicate business models are evolving from pure supply to solution provision—co-developing clinical trials and services with hospitals and pharma partners—thereby enhancing customer stickiness and pricing power. Key upstream elements include isotope production capacity (reactors and cyclotrons), radiochemical precursors and labeling reagents, and radiation-tolerant high-performance materials and precision electronics. Scintillators, target materials, and radiation-hard components directly affect imaging quality and production throughput, while radiopharmaceutical synthesis depends on GMP facilities and cold-chain logistics. Government and corporate disclosures emphasize that localizing production capacity, diversifying supply sources, and investing in infrastructure are essential to improve supply stability and enable sustainable industry growth.
The global Nuclide market size was estimated at USD 4125.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclide market.
Global Nuclide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Curium
MDS Nordion
IRE (Institute for Radioelements)
NTP Radioisotopes
JSC Isotope
ANM (ANSTO Nuclear Medicine)
Nusano
International Isotopes
NorthStar Medical Radioisotopes
China Isotope & Radiation
NRG
Polatom
ASP Isotopes
Rosatom
Eckert & Ziegler
Market Segmentation (by Type)
Tc-99m
F-18
I-131
Co-60
Other
Market Segmentation (by Application)
Industry
Medical
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclide Market
Overview of the regional outlook of the Nuclide Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
147 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Nuclide
- 1.2 Key Market Segments
- 1.2.1 Nuclide Segment by Type
- 1.2.2 Nuclide Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Nuclide Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Nuclide Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Nuclide Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Nuclide Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Nuclide Product Life Cycle
- 3.3 Global Nuclide Sales by Manufacturers (2020-2025)
- 3.4 Global Nuclide Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Nuclide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Nuclide Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Nuclide Market Competitive Situation and Trends
- 3.8.1 Nuclide Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Nuclide Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Nuclide Industry Chain Analysis
- 4.1 Nuclide Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Nuclide Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Nuclide Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Nuclide Market
- 5.7 ESG Ratings of Leading Companies
- 6 Nuclide Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Nuclide Sales Market Share by Type (2020-2025)
- 6.3 Global Nuclide Market Size by Type (2020-2025)
- 6.4 Global Nuclide Price by Type (2020-2025)
- 7 Nuclide Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Nuclide Market Sales by Application (2020-2025)
- 7.3 Global Nuclide Market Size (M USD) by Application (2020-2025)
- 7.4 Global Nuclide Sales Growth Rate by Application (2020-2025)
- 8 Nuclide Market Sales by Region
- 8.1 Global Nuclide Sales by Region
- 8.1.1 Global Nuclide Sales by Region
- 8.1.2 Global Nuclide Sales Market Share by Region
- 8.2 Global Nuclide Market Size by Region
- 8.2.1 Global Nuclide Market Size by Region
- 8.2.2 Global Nuclide Market Size by Region
- 8.3 North America
- 8.3.1 North America Nuclide Sales by Country
- 8.3.2 North America Nuclide Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Nuclide Sales by Country
- 8.4.2 Europe Nuclide Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Nuclide Sales by Region
- 8.5.2 Asia Pacific Nuclide Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Nuclide Sales by Country
- 8.6.2 South America Nuclide Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Nuclide Sales by Region
- 8.7.2 Middle East and Africa Nuclide Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Nuclide Market Production by Region
- 9.1 Global Production of Nuclide by Region(2020-2025)
- 9.2 Global Nuclide Revenue Market Share by Region (2020-2025)
- 9.3 Global Nuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Nuclide Production
- 9.4.1 North America Nuclide Production Growth Rate (2020-2025)
- 9.4.2 North America Nuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Nuclide Production
- 9.5.1 Europe Nuclide Production Growth Rate (2020-2025)
- 9.5.2 Europe Nuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Nuclide Production (2020-2025)
- 9.6.1 Japan Nuclide Production Growth Rate (2020-2025)
- 9.6.2 Japan Nuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Nuclide Production (2020-2025)
- 9.7.1 China Nuclide Production Growth Rate (2020-2025)
- 9.7.2 China Nuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Curium
- 10.1.1 Curium Basic Information
- 10.1.2 Curium Nuclide Product Overview
- 10.1.3 Curium Nuclide Product Market Performance
- 10.1.4 Curium Business Overview
- 10.1.5 Curium SWOT Analysis
- 10.1.6 Curium Recent Developments
- 10.2 MDS Nordion
- 10.2.1 MDS Nordion Basic Information
- 10.2.2 MDS Nordion Nuclide Product Overview
- 10.2.3 MDS Nordion Nuclide Product Market Performance
- 10.2.4 MDS Nordion Business Overview
- 10.2.5 MDS Nordion SWOT Analysis
- 10.2.6 MDS Nordion Recent Developments
- 10.3 IRE (Institute for Radioelements)
- 10.3.1 IRE (Institute for Radioelements) Basic Information
- 10.3.2 IRE (Institute for Radioelements) Nuclide Product Overview
- 10.3.3 IRE (Institute for Radioelements) Nuclide Product Market Performance
- 10.3.4 IRE (Institute for Radioelements) Business Overview
- 10.3.5 IRE (Institute for Radioelements) SWOT Analysis
- 10.3.6 IRE (Institute for Radioelements) Recent Developments
- 10.4 NTP Radioisotopes
- 10.4.1 NTP Radioisotopes Basic Information
- 10.4.2 NTP Radioisotopes Nuclide Product Overview
- 10.4.3 NTP Radioisotopes Nuclide Product Market Performance
- 10.4.4 NTP Radioisotopes Business Overview
- 10.4.5 NTP Radioisotopes Recent Developments
- 10.5 JSC Isotope
- 10.5.1 JSC Isotope Basic Information
- 10.5.2 JSC Isotope Nuclide Product Overview
- 10.5.3 JSC Isotope Nuclide Product Market Performance
- 10.5.4 JSC Isotope Business Overview
- 10.5.5 JSC Isotope Recent Developments
- 10.6 ANM (ANSTO Nuclear Medicine)
- 10.6.1 ANM (ANSTO Nuclear Medicine) Basic Information
- 10.6.2 ANM (ANSTO Nuclear Medicine) Nuclide Product Overview
- 10.6.3 ANM (ANSTO Nuclear Medicine) Nuclide Product Market Performance
- 10.6.4 ANM (ANSTO Nuclear Medicine) Business Overview
- 10.6.5 ANM (ANSTO Nuclear Medicine) Recent Developments
- 10.7 Nusano
- 10.7.1 Nusano Basic Information
- 10.7.2 Nusano Nuclide Product Overview
- 10.7.3 Nusano Nuclide Product Market Performance
- 10.7.4 Nusano Business Overview
- 10.7.5 Nusano Recent Developments
- 10.8 International Isotopes
- 10.8.1 International Isotopes Basic Information
- 10.8.2 International Isotopes Nuclide Product Overview
- 10.8.3 International Isotopes Nuclide Product Market Performance
- 10.8.4 International Isotopes Business Overview
- 10.8.5 International Isotopes Recent Developments
- 10.9 NorthStar Medical Radioisotopes
- 10.9.1 NorthStar Medical Radioisotopes Basic Information
- 10.9.2 NorthStar Medical Radioisotopes Nuclide Product Overview
- 10.9.3 NorthStar Medical Radioisotopes Nuclide Product Market Performance
- 10.9.4 NorthStar Medical Radioisotopes Business Overview
- 10.9.5 NorthStar Medical Radioisotopes Recent Developments
- 10.10 China Isotope and Radiation
- 10.10.1 China Isotope and Radiation Basic Information
- 10.10.2 China Isotope and Radiation Nuclide Product Overview
- 10.10.3 China Isotope and Radiation Nuclide Product Market Performance
- 10.10.4 China Isotope and Radiation Business Overview
- 10.10.5 China Isotope and Radiation Recent Developments
- 10.11 NRG
- 10.11.1 NRG Basic Information
- 10.11.2 NRG Nuclide Product Overview
- 10.11.3 NRG Nuclide Product Market Performance
- 10.11.4 NRG Business Overview
- 10.11.5 NRG Recent Developments
- 10.12 Polatom
- 10.12.1 Polatom Basic Information
- 10.12.2 Polatom Nuclide Product Overview
- 10.12.3 Polatom Nuclide Product Market Performance
- 10.12.4 Polatom Business Overview
- 10.12.5 Polatom Recent Developments
- 10.13 ASP Isotopes
- 10.13.1 ASP Isotopes Basic Information
- 10.13.2 ASP Isotopes Nuclide Product Overview
- 10.13.3 ASP Isotopes Nuclide Product Market Performance
- 10.13.4 ASP Isotopes Business Overview
- 10.13.5 ASP Isotopes Recent Developments
- 10.14 Rosatom
- 10.14.1 Rosatom Basic Information
- 10.14.2 Rosatom Nuclide Product Overview
- 10.14.3 Rosatom Nuclide Product Market Performance
- 10.14.4 Rosatom Business Overview
- 10.14.5 Rosatom Recent Developments
- 10.15 Eckert and Ziegler
- 10.15.1 Eckert and Ziegler Basic Information
- 10.15.2 Eckert and Ziegler Nuclide Product Overview
- 10.15.3 Eckert and Ziegler Nuclide Product Market Performance
- 10.15.4 Eckert and Ziegler Business Overview
- 10.15.5 Eckert and Ziegler Recent Developments
- 11 Nuclide Market Forecast by Region
- 11.1 Global Nuclide Market Size Forecast
- 11.2 Global Nuclide Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Nuclide Market Size Forecast by Country
- 11.2.3 Asia Pacific Nuclide Market Size Forecast by Region
- 11.2.4 South America Nuclide Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Nuclide by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Nuclide Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Nuclide by Type (2026-2035)
- 12.1.2 Global Nuclide Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Nuclide by Type (2026-2035)
- 12.2 Global Nuclide Market Forecast by Application (2026-2035)
- 12.2.1 Global Nuclide Sales (K Units) Forecast by Application
- 12.2.2 Global Nuclide Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
